Valproic acid (VPA) represents a new class of anticonvulsant of major therapeutic benefit. While its mode of action remains unknown, a considerable body of evidence suggests that it raises brain gamma-aminobutyric acid (GABA) levels. The initial phase of the proposed research will evaluate the hypothesis that VPA operates through inhibition of a citrate cycle enzyme (succinate:CoA ligase) with resulting diversion of glutamate away from alpha-ketoglutarate synthesis toward GABA synthesis. In addition, this project will explore differences in oxidative metabolism between synaptic and cell body mitochondria isolated from rat brain. This will be accomplished through polarographic measurements of oxygen uptake in isolated rat brain mitochondria and observation of changes induced by VPA and its metabolites. Isolated mitochondria will also be evaluated through measurement of metabolite flux by HPLC following introduction in vitro of various 14C labeled substrates. Perturbations in GABA and citrate cycle metabolism induced by VPA will be analyzed. This HPLC approach will open up a previously unavailable avenue for study of dynamic responses of intact, coupled brain mitochondria to a variety of changing metabolic conditions. This HPLC method will compliment the PI's interest in brain oxidative metabolism and will be applied to other problems of citrate cycle metabolism.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Clinical Investigator Award (CIA) (K08)
Project #
5K08NS001047-03
Application #
3083729
Study Section
Neurological Disorders Program Project Review B Committee (NSPB)
Project Start
1986-01-10
Project End
1990-12-31
Budget Start
1988-01-01
Budget End
1988-12-31
Support Year
3
Fiscal Year
1988
Total Cost
Indirect Cost
Name
University of Colorado Denver
Department
Type
Schools of Medicine
DUNS #
065391526
City
Aurora
State
CO
Country
United States
Zip Code
80045
Burkhardt, C; Kelly, J P; Lim, Y H et al. (1993) Neuroleptic medications inhibit complex I of the electron transport chain. Ann Neurol 33:512-7
Bennett, M C; Diamond, D M; Stryker, S L et al. (1992) Cytochrome oxidase inhibition: a novel animal model of Alzheimer's disease. J Geriatr Psychiatry Neurol 5:93-101
Bindoff, L A; Birch-Machin, M A; Cartlidge, N E et al. (1991) Respiratory chain abnormalities in skeletal muscle from patients with Parkinson's disease. J Neurol Sci 104:203-8
Bindoff, L A; Birch-Machin, M; Cartlidge, N E et al. (1989) Mitochondrial function in Parkinson's disease. Lancet 2:49
Rosenberg, A A; Parks, J K; Murdaugh, E et al. (1989) Mitochondrial function after asphyxia in newborn lambs. Stroke 20:674-9